My Papers – Page 2 – Healthcare Economist

A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE’s Size of Benefit Multiplier

2023-07-06Jason Shafrin

That is the title of a study published today with co-authors Sabiha Quddus, Moises Marin, and Dennis Scanlon PhD. The abstract is below. ObjectiveTo estimate the incremental health benefits of pharmaceutical innovations approved between 2011-2021 and the share that would surpass the National Institute for Health and Care Excellence (NICE) ‘size of benefit’ decision weight…

Quantifying the Long-Run Economic and Health Impact of Reduced Intellectual Property Protections for New Drugs

2023-05-302023-05-30Jason Shafrin

That is the title of a new working paper written by myself, any my FTI Consulting colleagues Sabiha Quddus and Suhail Thahir. The abstract is below. Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical…

ISPOR 2023

2023-05-07Jason Shafrin

If you’re attending the ISPOR 2023 conference in Boston, MA please feel free to come by view some of my research. This includes the following: Podium Presentation #108: Economic Evaluations of Rare Diseases: “Quantifying the Insurance and Altruism Value for Rare Diseases: A Case Study for Duchenne Muscular Dystrophy”. Jason Shafrin will be presenting this work as…

A Strategy For Value-Based Drug Pricing Under The Inflation Reduction Act

2023-05-042023-05-04Jason Shafrin

This is the title of my Health Affairs Forefront article published today alongside co-authors Darius Lakdawalla, Jalpa Doshi, Louis Garrison, Anup Malani, Peter Neumann, Charles Phelps, Adrian Towse, and Richard Willke. The article begins by discussing some of the pros and cons of different approaches for CMS to set the maximum fair price (MFP). Across…

1000 Citations

2023-04-20Jason Shafrin

I just reached 1000 citations for my research in Google Scholar. Very exciting! To read my research, click here.

USC White Paper: “Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market”

2023-04-13Jason Shafrin

That is the title of a new USC Schaeffer Center white paper authored by Dana Goldman, Joe Grogan, Darius Lakdawalla, Barry Liden, Kyi-Sin Than, Erin Trish and myself. An excerpt from the press release is below, and the full white paper is here (HTML, PDF). 1. Bring transparency and a focus on value to the…

2022 Publications

2023-01-04Jason Shafrin

As we have turned the leaf to 2023, I figured I’d share the publications I had last year: Publications Forma F, Chiu K, Shafrin J, Boskovic DH, Veeranki SP. Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. Digital health. 2022 Mar;8:20552076221084472. Jackisch…

The Role of Intellectual Property in the Biopharmaceutical Sector

2022-12-28Jason Shafrin

That is the title of an FTI White Paper published this year where I was a co-author alongside Antoine Mialhe, Sabiha Quddus, Anne-Sophie Deman, Suhail Thahir and Agnes Sipiczki. The role of Intellectual property (IP) in the development of COVID-19 vaccines and therapeutics became a central tenant in discussions on how to ensure access to…

EHR data analysis of the impact of suboptimal treatment of antimicrobial resistance

2022-11-072022-11-06Jason ShafrinLeave a comment

I am happy to announce that along with co-authors Alen Marijam, Ashish V. Joshi, Fanny S. Mitrani-Gold, Katie Everson, Rifat Tuly, Peter Rosenquist, Michael Gillam & Maria Elena Ruiz, I have a new paper published in Antimicrobial Resistance & Infection Control titled “Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among…

Lecture on Health Care Economics at USC

2022-10-05Jason ShafrinLeave a comment

Thank you to Dr. Daniel Tomaszewski and the University of Southern California’s Health Care Decision Analysis (HCDA) program for brining me in as a guest speaker this weekend. I truly enjoyed my time with the students. As they posted on LinkedIn: Thanks to guest speaker Jason Shafrin of FTI Consulting, for joining us in the Health Economics…